| Urokinase Receptor Interacts with αvβ5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer MV Carriero, SD Vecchio, M Capozzoli, P Franco, L Fontana, A Zannetti, ... Cancer research 59 (20), 5307-5314, 1999 | 192 | 1999 |
| Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma A Zannetti, S Del Vecchio, MV Carriero, R Fonti, P Franco, G Botti, ... Cancer research 60 (6), 1546-1551, 2000 | 168 | 2000 |
| Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer BS Hill, A Sarnella, G D’Avino, A Zannetti Seminars in cancer biology 60, 202-213, 2020 | 140 | 2020 |
| In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging L Aloj, C Caracò, M Panico, A Zannetti, S Del Vecchio, D Tesauro, ... Journal of Nuclear Medicine 45 (3), 485-494, 2004 | 124 | 2004 |
| Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models R Rosa, R Marciano, U Malapelle, L Formisano, L Nappi, C D'Amato, ... Clinical cancer research 19 (1), 138-147, 2013 | 123 | 2013 |
| Nuclear imaging in cancer theranostics S Del Vecchio, A Zannetti, R Fonti, L Pace, M Salvatore The Quarterly Journal of Nuclear Medicine and Molecular Imaging 51 (2), 152-63, 2007 | 116 | 2007 |
| Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype BS Hill, A Pelagalli, N Passaro, A Zannetti Oncotarget 8 (42), 73296, 2017 | 106 | 2017 |
| Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers S Camorani, E Crescenzi, M Gramanzini, M Fedele, A Zannetti, L Cerchia Scientific Reports 7 (1), 46659, 2017 | 97 | 2017 |
| A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion R Fontanella, A Pelagalli, A Nardelli, C D'Alterio, C Ieranò, L Cerchia, ... Cancer letters 370 (1), 100-107, 2016 | 89 | 2016 |
| Inhibition of bone marrow-derived mesenchymal stem cells homing towards triple-negative breast cancer microenvironment using an anti-PDGFRβ aptamer S Camorani, BS Hill, R Fontanella, A Greco, M Gramanzini, L Auletta, ... Theranostics 7 (14), 3595, 2017 | 82 | 2017 |
| Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors L Agnello, S Tortorella, A d’Argenio, C Carbone, S Camorani, E Locatelli, ... Journal of Experimental & Clinical Cancer Research 40, 1-17, 2021 | 70 | 2021 |
| Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma R Fonti, S Del Vecchio, A Zannetti, A De Renzo, F Di Gennaro, L Catalano, ... European journal of nuclear medicine 28, 214-220, 2001 | 70 | 2001 |
| Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma S Del Vecchio, A Zannetti, L Aloj, C Caracò, A Ciarmiello, M Salvatore European Journal of Nuclear Medicine and Molecular Imaging 30, 879-887, 2003 | 62 | 2003 |
| Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer S Camorani, BS Hill, F Collina, S Gargiulo, M Napolitano, M Cantile, ... Theranostics 8 (18), 5178, 2018 | 61 | 2018 |
| Imaging of αvβ3 Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with αvβ5 A Zannetti, S Del Vecchio, F Iommelli, A Del Gatto, S De Luca, L Zaccaro, ... Clinical cancer research 15 (16), 5224-5233, 2009 | 56 | 2009 |
| Insulin-stimulated hydrolysis of phosphatidylcholine by phospholipase C and phospholipase D in cultured rat hepatocytes V Donchenko, A Zannetti, PM Baldini Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1222 (3), 492-500, 1994 | 55 | 1994 |
| Inhibition of AQP1 hampers osteosarcoma and hepatocellular carcinoma progression mediated by bone marrow-derived mesenchymal stem cells A Pelagalli, A Nardelli, R Fontanella, A Zannetti International journal of molecular sciences 17 (7), 1102, 2016 | 54 | 2016 |
| TNBC challenge: oligonucleotide aptamers for new imaging and therapy modalities S Camorani, M Fedele, A Zannetti, L Cerchia Pharmaceuticals 11 (4), 123, 2018 | 48 | 2018 |
| Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer S Camorani, M Passariello, L Agnello, S Esposito, F Collina, M Cantile, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 47 | 2020 |
| In vivo imaging and characterization of [18F] DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET C Vicidomini, M Panico, A Greco, S Gargiulo, ARD Coda, A Zannetti, ... Nuclear Medicine and Biology 42 (3), 309-316, 2015 | 46 | 2015 |
